×
Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.
NCR1 Antikörper
NCR1
Reaktivität: Human
FACS
Wirt: Maus
Monoclonal
9E2
unconjugated
Produktnummer ABIN2664588
Produktdetails anti-NCR1 Antikörper
(ausblenden)
Target
Alle NCR1 Antikörper anzeigen
NCR1
(Natural Cytotoxicity Triggering Receptor 1 (NCR1))
Reaktivität
Alle Reaktivitäten für NCR1 Antikörper
Human
Wirt
Alle Wirte für NCR1 Antikörper
Maus
Klonalität
Alle Klonalitäten für NCR1 Antikörper
Monoklonal
Konjugat
Alle Konjugate für NCR1 Antikörper
Dieser NCR1 Antikörper ist unkonjugiert
Applikation
Alle Applikationen für NCR1 Antikörper
Flow Cytometry (FACS)
Aufreinigung
The antibody was purified by affinity chromatography.
Klon
9E2
Isotyp
IgG1 kappa
Top Product
Discover our top product NCR1 Primärantikörper
Alternativen
(anzeigen)
Anwendungsinformationen
(ausblenden)
Applikationshinweise
Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Handhabung
(ausblenden)
Konzentration
0.5 mg/mL
Buffer
Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C
Informationen zur Lagerung
The antibody solution should be stored undiluted between 2°C and 8°C.
Details zu NCR1
(ausblenden)
Target
NCR1
(Natural Cytotoxicity Triggering Receptor 1 (NCR1))
Andere Bezeichnung
CD335 (NCR1 Produkte )
Hintergrund
CD335, also known as NKp46, is a member of the natural cytotoxicity receptor (NCR) family which triggers cytotoxicity in NK cells. CD335 is direct-ly involved in target cell recognition and lysis, and is exclusively expressed on CD3-CD56+ NK cells, suggesting it is a universal marker for NK cells. NKp46, along with NKp30 and NKp44, is referred to as a natural cytoxicity receptor (NCR) and plays a very important role in killing virus-infected tumor cells and MHC-class I-unprotected cells.
Pathways
Regulation of Leukocyte Mediated Immunity
Zuletzt angesehen
(ausblenden)